{"result": "\n{\n    \"title\": \"Sepsis and Septic Shock Clinical Trials in the United States\",\n    \"summary\": \"The community is centered around clinical trials related to sepsis and septic shock, primarily conducted in the United States. Key entities include the Data and Safety Monitoring Board, SAS Institute, and various patient groups involved in trials like the ProCESS and ALBIOS studies. These trials are significant due to their impact on understanding and treating severe sepsis and septic shock, which are major health concerns in the United States.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of sepsis and septic shock as major health issues and the extensive research efforts to address them.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significance of Sepsis and Septic Shock in the United States\",\n            \"explanation\": \"Severe sepsis and septic shock are significant health issues in the United States, with a high incidence and mortality rate. In 1995, severe sepsis was a major cause of death in the country, highlighting the critical need for effective treatment strategies [Data: Entities (41); Relationships (127, 236, 238)].\"\n        },\n        {\n            \"summary\": \"Role of the Data and Safety Monitoring Board\",\n            \"explanation\": \"The Data and Safety Monitoring Board plays a crucial role in overseeing clinical trials related to sepsis and septic shock. This independent group ensures the safety of participants and the integrity of data collected during studies like the ALBIOS trial. They conduct interim analyses and make recommendations regarding the continuation or termination of trials based on their findings [Data: Entities (136); Relationships (504, 538, 550, 542, 543)].\"\n        },\n        {\n            \"summary\": \"Involvement of the SAS Institute\",\n            \"explanation\": \"The SAS Institute, based in Cary, North Carolina, provides the statistical software used for data analysis in these clinical trials. Their software is essential for analyzing complex datasets, ensuring accurate and reliable results in research settings. This highlights the importance of robust data analysis tools in clinical research [Data: Entities (54); Relationships (257, 250, 232, 255, 251)].\"\n        },\n        {\n            \"summary\": \"ProCESS Trial and its Contributions\",\n            \"explanation\": \"The ProCESS trial is a significant study that evaluated the effectiveness of early goal-directed therapy (EGDT) in managing septic shock. Conducted across 31 emergency departments in the United States, this trial provides valuable insights into treatment strategies for septic shock, contributing to the broader understanding of this critical condition [Data: Entities (499); Relationships (737, 235, 237)].\"\n        },\n        {\n            \"summary\": \"ALBIOS Study's Impact on Sepsis Treatment\",\n            \"explanation\": \"The ALBIOS study, conducted in 100 intensive care units in Italy, investigates the effects of albumin and crystalloids in patients with severe sepsis. This multicenter, open-label, randomized controlled trial provides important data on the safety and efficacy of albumin administration, influencing treatment protocols for critically ill patients [Data: Entities (131); Relationships (240, 535, 536, 534)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n41,UNITED STATES,\"The United States is a country where severe sepsis was a significant cause of death in 1995. It is estimated that approximately 750,000 to 751,000 cases of sepsis or septic shock occur each year, with at least 225,000 resulting in fatalities. The United States was one of the countries where the study, including the ProCESS trial, was conducted. This trial took place across 31 emergency departments and 48 hospitals, with various centers participating in the research.\",11\n129,PATIENTS,\"The patients are individuals enrolled in a clinical study, specifically focusing on those with Acute Respiratory Distress Syndrome (ARDS) and septic shock. These patients are part of a clinical trial where they receive interventions for septic shock. The study includes patients who are older than 18 years, require vasopressors, and meet specific criteria for inclusion in the study.\",10\n136,DATA AND SAFETY MONITORING BOARD,\"The Data and Safety Monitoring Board is an independent group comprising three experts in the field, responsible for overseeing the conduct of clinical trials, such as the ALBIOS trial. This board plays a crucial role in ensuring the safety of participants and the integrity of the data collected during the study. It is tasked with monitoring the trial's safety and data integrity, conducting interim analyses, and making recommendations regarding the study protocol. The board has the authority to decide whether to continue or discontinue the trial based on their findings. During the ALBIOS trial, the Data and Safety Monitoring Board performed an interim analysis after the enrollment of 700 patients, ensuring the ongoing safety and integrity of the trial.\",14\n95,FISHER'S EXACT TEST,\"Fisher's Exact Test is a statistical significance test primarily used in the analysis of contingency tables. It is employed in studies to compare baseline variables and secondary outcomes, as well as to determine if there are nonrandom associations between two categorical variables. This test is particularly useful in research settings where the sample size is small, and it provides a precise method for evaluating the association between categorical variables.\",5\n499,PROCESS,\"The ProCESS trial is a study that evaluated the effectiveness of EGDT in managing septic shock, similar to the study described in the text\",2\n581,PRONE GROUP,PRONE GROUP refers to a group of patients in the study who were assigned to be turned to the prone position for treatment. These patients were positioned prone during the treatment as part of the study protocol.,6\n582,SUPINE GROUP,The SUPINE GROUP is a cohort of patients in the study who were assigned to remain in a supine position during treatment. This group was specifically positioned in a semirecumbent posture as part of the study's protocol to evaluate the effects of this positioning on treatment outcomes.,6\n54,SAS INSTITUTE,\"SAS Institute is a company based in Cary, NC, renowned for developing the SAS statistical software. This software is widely used for data analysis, particularly in the context of clinical trials and studies. As a leading provider of statistical software, SAS Institute plays a crucial role in facilitating the analysis of complex data sets, ensuring accurate and reliable results in various research and trial settings.\",11\n17,STEERING COMMITTEE,\"The Steering Committee is a group responsible for overseeing the ALBIOS study. They ensure the accuracy of data, completeness of analysis, and fidelity of the study to the protocol. The committee is tasked with designing, executing, and analyzing the data of the study, and they collaborated with Eli Lilly to design the study and write the first draft of the manuscript. They meet monthly to ensure the study's progress and adherence to protocols. Additionally, the Steering Committee made the decision to terminate the trial based on recommendations from the data monitoring committee.\",8\n231,O'BRIEN–FLEMING METHOD,\"The O'Brien–Fleming method is a statistical approach utilized to adjust significance levels during interim analyses in clinical trials. It is specifically designed to calculate alpha spending, which helps in determining early stopping criteria for the trial. This method ensures that the integrity of the trial is maintained while allowing for potential early conclusions based on interim data.\",2\n130,INVESTIGATORS,\"The INVESTIGATORS are a group of researchers conducting a study on resuscitation therapies for patients with severe sepsis and septic shock. They are responsible for collecting data, analyzing it, and writing the study. Additionally, they ensure adherence to guidelines at each meeting and assess patients during the study. The investigators also reviewed feasibility data from the pilot phase of the study, highlighting their comprehensive role in both the practical and analytical aspects of the research.\",12\n33,CLINICIANS,CLINICIANS are healthcare professionals involved in the treatment and management of patients participating in the trial.,3\n131,ALBIOS STUDY,\"The Albumin Italian Outcome Sepsis (ALBIOS) study is a multicenter, open-label, randomized, controlled trial conducted in 100 intensive care units in Italy to investigate the effects of albumin and crystalloids in patients with severe sepsis\",8\n251,WRITING COMMITTEE,\"The WRITING COMMITTEE is a group responsible for writing the article about the trial. This committee ensures the accuracy and completeness of the study data and adherence to the protocol. The Writing Committee, which includes the first and last three authors, collaborates with investigators to write the manuscript, ensuring that the article is comprehensive and precise.\",6\n194,NHLBI,\"The National Heart, Lung, and Blood Institute (NHLBI) is an organization that played a significant role in overseeing a clinical trial. It endorsed the decision to stop the trial due to futility, indicating that the trial was unlikely to achieve its intended outcomes. Additionally, the NHLBI provided oversight through a central institutional review board and a data and safety monitoring board, ensuring that the trial adhered to ethical standards and maintained participant safety throughout its duration.\",5\n583,AUTHORS,Individuals who contributed to the writing of the manuscript and vouch for the accuracy of the data and analysis,2\n43,INTENSIVE CARE UNITS,\"INTENSIVE CARE UNITS: The intensive care units (ICUs) mentioned are involved in significant clinical studies. There were 52 participating ICUs involved in the CORTICUS study, which focused on critical care research. Additionally, 100 ICUs in Italy participated in the ALBIOS study, highlighting their role in advancing medical knowledge and treatment practices within intensive care settings.\",3\n199,PETAL STEERING COMMITTEE,The committee that accepted the decision to stop the trial for futility,3\n166,INTERIM ANALYSIS,\"INTERIM ANALYSIS is an analysis conducted before the completion of a study to assess early results. Specifically, it is performed 28 days after half the patients have been enrolled in the study.\",2\n421,KETOCONAZOLE,A trial comparing ketoconazole with placebo was conducted as part of the study,1\n422,LISOFYLLINE,A trial comparing lisofylline with placebo was conducted as part of the study,1\n229,INDEPENDENT DATA MONITORING COMMITTEE,\"The Independent Data Monitoring Committee is a committee responsible for reviewing clinical outcomes and recommending the continuation of the trial. Additionally, the committee is tasked with reviewing interim analyses of the trial to ensure the integrity and safety of the study.\",3\n557,INDEPENDENT STATISTICIAN,An independent statistician performed interim analyses for the trial,2\n608,KAPLAN–MEIER ANALYSIS,A statistical method used to estimate the survival function from lifetime data,1\n609,QUALITY-ASSURANCE EVALUATIONS,Assessments conducted to ensure the quality and reliability of the study's data and methods,1\n226,PHYSICIANS,\"PHYSICIANS are medical professionals responsible for enrolling patients in the study, managing their treatment, prescribing treatments, and monitoring patients throughout the study.\",3\n55,CARY,\"Cary is a city in North Carolina, USA, where the SAS Institute is located\",1\n164,SAS STATISTICAL SOFTWARE,,1\n227,CENTRAL WEB-BASED RANDOMIZATION SYSTEM,The system used to randomly assign patients to different study groups,1\n620,FRENCH HEALTH CARE SYSTEM,\"The health care system in France, with which patients must be affiliated to be included in the study\",1\n132,ITALIAN MEDICINES AGENCY,\"The Italian Medicines Agency funded the ALBIOS study but did not participate in its conduct, reporting, or supply of study fluids\",1\n135,ITALY,Country where the ALBIOS study was conducted across 100 intensive care units,1\n133,COCHRANE INJURIES GROUP ALBUMIN REVIEWERS,A group that reported in 1998 that albumin administration might be harmful in critically ill patients compared to crystalloid solutions,1\n580,RESEARCH FELLOWS,Research fellows are individuals responsible for regularly monitoring the centers involved in the study,1\n587,MORTALITY AT DAY 28,The primary endpoint of the study measuring mortality 28 days after treatment,2\n588,MORTALITY AT DAY 90,A secondary endpoint of the study measuring mortality 90 days after treatment,2\n159,WILCOXON RANK-SUM TEST,\"The Wilcoxon Rank-Sum Test is a non-parametric statistical test used to compare two groups. It is particularly useful for comparing secondary outcomes in studies where the data may not meet the assumptions required for parametric tests. This test is often employed when the data are ordinal or when the sample sizes are small, providing a robust alternative to the t-test for independent samples.\",2\n198,TRIAL HOSPITAL,\"The hospital where the trial took place, including transfers to other hospitals and long-term acute care facilities\",1\n228,INTENSIVISTS,Specialized physicians who reviewed chest radiographs for evidence of barotrauma in patients,1\n160,HODGES–LEHMANN METHOD,A statistical method used to estimate the median of paired differences between observations,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n127,SEPTIC SHOCK,UNITED STATES,\"Severe sepsis, which can lead to septic shock, was a major cause of death in the United States in 1995\",81\n135,SEPTIC SHOCK,PATIENTS,Patients in the trial were suffering from septic shock,80\n544,DATA AND SAFETY MONITORING BOARD,EGDT,The data and safety monitoring board was consulted during the study involving EGDT,65\n317,ICU,DATA AND SAFETY MONITORING BOARD,The Data and Safety Monitoring Board performed interim analyses on patients enrolled in the ICU,60\n419,FISHER'S EXACT TEST,EGDT,Fisher's exact test was used to analyze the primary outcome of the study involving EGDT,56\n504,TRIAL,DATA AND SAFETY MONITORING BOARD,The Data and Safety Monitoring Board monitored the trial's safety and data integrity,54\n737,EGDT,PROCESS,The study's findings on EGDT were compared with those of the ProCESS trial,53\n337,ICU,PRONE GROUP,Patients in the prone group are treated in the ICU,52\n338,ICU,SUPINE GROUP,Patients in the supine group are treated in the ICU,52\n257,SAS INSTITUTE,TRIAL,SAS Institute provided the statistical software used for the trial's analysis,51\n60,STEERING COMMITTEE,TRIAL,The steering committee decided to terminate the trial,48\n233,UNITED STATES,ARDS,The trial studying ARDS was conducted in the United States,43\n489,TRIAL,O'BRIEN–FLEMING METHOD,The O'Brien–Fleming method was used to determine early stopping criteria in the trial,42\n97,PLACEBO,SAS INSTITUTE,SAS Institute's software was used to analyze the effects of placebo in the study,42\n254,SAS INSTITUTE,USUAL-CARE GROUP,SAS software from SAS Institute was used to analyze data from the usual-care group,29\n442,MULTICENTER TRIAL,INVESTIGATORS,Investigators were responsible for conducting and overseeing the multicenter trial,28\n236,UNITED STATES,SEVERE SEPSIS,\"Severe sepsis is a significant health issue in the United States, with a high incidence and mortality rate\",28\n528,INVESTIGATORS,EARLY GOAL-DIRECTED THERAPY,Investigators conducted the study to assess the benefits of early goal-directed therapy,27\n253,SAS INSTITUTE,EGDT GROUP,SAS software from SAS Institute was used to analyze data from the EGDT group,27\n547,DATA AND SAFETY MONITORING BOARD,\"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE\",\"The data and safety monitoring board conducted interim analyses for the study funded by the National Heart, Lung, and Blood Institute\",26\n250,SAS INSTITUTE,DATA AND SAFETY MONITORING BOARD,SAS Institute provided the software used by the Data and Safety Monitoring Board for statistical analysis,25\n20,DROTAA,CLINICIANS,\"Clinicians were previously using DrotAA to treat patients with septic shock, but the treatment is no longer available\",24\n527,INVESTIGATORS,STANDARD THERAPY,Investigators influenced the care of patients in the standard therapy group,24\n252,SAS INSTITUTE,ACETAMINOPHEN,SAS Institute's software was used to analyze the effects of acetaminophen in the study,24\n239,UNITED STATES,VASOPRESSIN,The vasopressin trial was conducted in the United States,24\n255,SAS INSTITUTE,\"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE\",\"SAS software from SAS Institute was used for statistical analysis in the study by the National Heart, Lung, and Blood Institute\",23\n538,ALBIOS STUDY,DATA AND SAFETY MONITORING BOARD,The Data and Safety Monitoring Board oversaw the conduct of the ALBIOS trial,22\n62,STEERING COMMITTEE,DATA AND SAFETY MONITORING BOARD,The steering committee and the data and safety monitoring board work together to oversee the trial,22\n524,PATIENTS,INVESTIGATORS,Investigators are responsible for assessing and collecting data from patients during the study. They also analyze the collected data as part of their role in the study.,22\n521,PATIENTS,HFOV,HFOV is applied to patients with life-threatening refractory hypoxemia,22\n232,UNITED STATES,SAS INSTITUTE,SAS Institute is a U.S.-based organization that provided the software for analysis,22\n235,UNITED STATES,PROCESS TRIAL,The ProCESS trial was conducted in 31 emergency departments across the United States,22\n433,SUPPLEMENTARY APPENDIX,WRITING COMMITTEE,The Supplementary Appendix contains additional methods and figures related to the study overseen by the writing committee,22\n452,MULTICENTER TRIAL,WRITING COMMITTEE,The writing committee authored the article about the trial,22\n234,UNITED STATES,HIGH-FREQUENCY OSCILLATORY VENTILATION (HFOV),The United States was one of the countries where the HFOV study was conducted,21\n548,DATA AND SAFETY MONITORING BOARD,SUPINE GROUP,The board recommended the continuation of the trial involving the supine group,20\n549,DATA AND SAFETY MONITORING BOARD,PRONE GROUP,The board recommended the continuation of the trial involving the prone group,20\n542,DATA AND SAFETY MONITORING BOARD,NHLBI,The Data and Safety Monitoring Board's decision to stop the trial was endorsed by the NHLBI,19\n438,SUPPLEMENTARY APPENDIX,AUTHORS,Authors provide additional information in the Supplementary Appendix,18\n380,CISATRACURIUM,FISHER'S EXACT TEST,Fisher's exact test was used to assess differences between the cisatracurium and placebo groups,18\n214,FRANCE,INTENSIVE CARE UNITS,The study on septic shock was conducted in 19 intensive care units across France,18\n533,INVESTIGATORS,WRITING COMMITTEE,Investigators collaborate with the Writing Committee in the manuscript preparation,18\n238,UNITED STATES,SEVERE SEPSIS AND SEPTIC SHOCK,The United States experiences a high incidence of severe sepsis and septic shock,18\n543,DATA AND SAFETY MONITORING BOARD,PETAL STEERING COMMITTEE,The Data and Safety Monitoring Board's decision to stop the trial was accepted by the PETAL Steering Committee,17\n421,FISHER'S EXACT TEST,INVESTIGATORS,Investigators used Fisher's exact test to analyze differences between study groups,17\n532,INVESTIGATORS,ADVERSE EVENTS,Investigators recorded adverse events to assess safety during the study,17\n58,STEERING COMMITTEE,ALBIOS STUDY,The Steering Committee designed and executed the ALBIOS study,16\n364,NEJM.ORG,ALBIOS STUDY,The full text of the ALBIOS study article is available on NEJM.org,16\n550,DATA AND SAFETY MONITORING BOARD,INTERIM ANALYSIS,The interim analysis data was sent to the board for decision-making,16\n230,UNITED STATES,NHLBI,The NHLBI is a U.S.-based organization involved in the trial,16\n522,PATIENTS,PRONE GROUP,Patients are assigned to the prone group for specific treatment protocols,16\n523,PATIENTS,SUPINE GROUP,Patients are assigned to the supine group for specific treatment protocols,16\n26,ELI LILLY,STEERING COMMITTEE,The steering committee designed the study in collaboration with Eli Lilly,16\n187,CLINICIANS,INVESTIGATORS,Investigators and clinicians collaborated in the management and execution of the trial,15\n545,DATA AND SAFETY MONITORING BOARD,KETOCONAZOLE,The Data and Safety Monitoring Board conducted interim analyses for the ketoconazole trial,15\n546,DATA AND SAFETY MONITORING BOARD,LISOFYLLINE,The Data and Safety Monitoring Board conducted interim analyses for the lisofylline trial,15\n526,INVESTIGATORS,INDEPENDENT DATA MONITORING COMMITTEE,Investigators provided data to the independent data monitoring committee for review,15\n241,INTENSIVE CARE UNITS,CORTICUS STUDY,The CORTICUS study was conducted in 52 participating intensive care units,15\n530,INVESTIGATORS,O'BRIEN–FLEMING METHOD,Investigators used the O'Brien–Fleming method to adjust significance levels in interim analyses,14\n231,UNITED STATES,PETAL STEERING COMMITTEE,The PETAL Steering Committee is involved in the trial conducted in the United States,14\n64,STEERING COMMITTEE,WRITING COMMITTEE,The Steering Committee collaborates with the Writing Committee to ensure the study's fidelity and accuracy,14\n186,CLINICIANS,PATIENTS,Clinicians provided care and treatment to patients participating in the trial,13\n256,SAS INSTITUTE,INDEPENDENT STATISTICIAN,The independent statistician used SAS software for data analysis,13\n529,INVESTIGATORS,KAPLAN–MEIER ANALYSIS,Investigators used Kaplan–Meier analysis to construct survival curves,13\n531,INVESTIGATORS,QUALITY-ASSURANCE EVALUATIONS,Investigators conducted quality-assurance evaluations to enhance the quality of measurements,13\n519,PATIENTS,PHYSICIANS,Physicians were responsible for enrolling patients and managing their treatment,13\n473,DATA AND SAFETY MONITORING COMMITTEE,PATIENTS,The Data and Safety Monitoring Committee oversees the safety of the patients during the trial,13\n237,UNITED STATES,PROCESS,\"The ProCESS trial, similar to the study described, was conducted in the United States\",13\n536,ALBIOS STUDY,SAFE STUDY,Both studies investigated the effects of albumin administration in critically ill patients,12\n249,SAS INSTITUTE,CARY,\"SAS Institute is located in Cary, North Carolina\",12\n264,HOSPITAL,PHYSICIANS,Physicians treated and monitored patients in the hospital during the trial,12\n1008,PRONE GROUP,SUPINE GROUP,\"The PRONE GROUP and SUPINE GROUP are two distinct patient groups involved in a study that compares different patient positioning. Each group follows its own unique treatment protocols, contributing to the research's aim of evaluating the effects of these varied positions on patient outcomes.\",12\n251,SAS INSTITUTE,SAS STATISTICAL SOFTWARE,SAS Institute developed the SAS statistical software used in the study,12\n240,INTENSIVE CARE UNITS,ALBIOS STUDY,The ALBIOS study was conducted in 100 intensive care units,11\n520,PATIENTS,CENTRAL WEB-BASED RANDOMIZATION SYSTEM,Patients were randomly assigned to study groups using the central web-based randomization system,11\n525,PATIENTS,FRENCH HEALTH CARE SYSTEM,Patients must be affiliated with the French health care system to be included in the study,11\n59,STEERING COMMITTEE,INDEPENDENT DATA MONITORING COMMITTEE,The independent data monitoring committee recommended trial continuation to the steering committee,11\n696,WRITING COMMITTEE,EXECUTIVE COMMITTEE,The Executive Committee made the decision to publish the article written by the Writing Committee,11\n692,PARTICIPATING SITES,WRITING COMMITTEE,The writing committee ensured the accuracy and completeness of data from the participating sites,11\n63,STEERING COMMITTEE,AUTHORS,Authors are likely part of the steering committee overseeing the trial,10\n534,ALBIOS STUDY,ITALIAN MEDICINES AGENCY,The ALBIOS study was funded by the Italian Medicines Agency,9\n535,ALBIOS STUDY,ITALY,The ALBIOS study was conducted in 100 intensive care units in Italy,9\n537,ALBIOS STUDY,COCHRANE INJURIES GROUP ALBUMIN REVIEWERS,\"The ALBIOS study was conducted to further investigate the safety and efficacy of albumin administration, which was previously questioned by the Cochrane Injuries Group Albumin Reviewers\",9\n61,STEERING COMMITTEE,RESEARCH FELLOWS,Research fellows report to the steering committee as part of the trial's oversight,9\n591,INTERIM ANALYSIS,MORTALITY,Interim analysis includes assessing mortality rates at different time points,8\n1009,PRONE GROUP,MORTALITY AT DAY 28,The study measured mortality at day 28 for the prone group,8\n1011,SUPINE GROUP,MORTALITY AT DAY 28,The study measured mortality at day 28 for the supine group,8\n1010,PRONE GROUP,MORTALITY AT DAY 90,The study measured mortality at day 90 for the prone group,8\n1012,SUPINE GROUP,MORTALITY AT DAY 90,The study measured mortality at day 90 for the supine group,8\n629,NHLBI,PETAL STEERING COMMITTEE,The NHLBI endorsed and the PETAL Steering Committee accepted the decision to stop the trial for futility,8\n623,ACURASYS TRIAL,NHLBI,The ACURASYS trial's protocol was overseen by the NHLBI,8\n420,FISHER'S EXACT TEST,BASELINE VARIABLES,Fisher's exact test was used to compare baseline variables in the study,7\n422,FISHER'S EXACT TEST,WILCOXON RANK-SUM TEST,Both tests were used to compare secondary outcomes in the study,7\n628,NHLBI,TRIAL HOSPITAL,The NHLBI provided oversight for the trial conducted at the trial hospital,6\n667,INDEPENDENT DATA MONITORING COMMITTEE,INDEPENDENT STATISTICIAN,The independent statistician's analyses were reviewed by the Independent Data Monitoring Committee,5\n666,PHYSICIANS,INTENSIVISTS,Physicians and intensivists worked together to monitor and treat patients in the study,4\n587,WILCOXON RANK-SUM TEST,HODGES–LEHMANN METHOD,The Wilcoxon rank-sum test uses the Hodges–Lehmann method to calculate point estimates,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}